BioSpace News Archive

Business

Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors

The Antengene board announced the appointment of Mr. Mark J. Alles as an independent director of the company, effective January 2, 2020. Mr. Alles is the former Chairman and Chief Executive Officer of Celgene Corporation, now a subsidiary of Bristol-Myers Squibb Company.

January 8, 2020
·
4 min read
BioLineRx to Present at the 2020 Biotech Showcase

BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology, announced that management will provide a corporate update at the 2020 Biotech Showcase in San Francisco, California.

January 8, 2020
·
3 min read
Business

Compugen Announces Appointment of Dr. Oliver Froescheis as Senior Vice President, Corporate and Business Development

Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced the appointment of Oliver Froescheis, Ph.D., as Senior Vice President, Corporate and Business Development.

January 8, 2020
·
5 min read
Policy

Aruvant Receives FDA Rare Pediatric Disease Designation for ARU-1801 for the Treatment of Sickle Cell Disease

ARU-1801 is being developed as a potential one-time treatment for patients suffering from sickle cell disease and β-thalassemia

January 8, 2020
·
3 min read
Deals

Altavant Sciences Acquires Onspira Therapeutics, Adding a Potentially Life-Saving Treatment for Post-Lung Transplant Patients to the Altavant Pipeline

Altavant plans to develop OSP-101 for the treatment of bronchiolitis obliterans syndrome, the leading cause of morbidity and mortality in post-lung transplant patients

January 8, 2020
·
6 min read
Business

Provention Bio Appoints Jason Hoitt as Chief Commercial Officer

Provention Bio, Inc. announced the appointment of Jason Hoitt as Chief Commercial Officer.

January 8, 2020
·
4 min read
Business

Revitope Oncology Appoints Steve Arkinstall, D.Phil., as Chief Executive Officer

Revitope Oncology, Inc., a cancer therapeutics company advancing a novel class of tumor-specific bispecific antibody therapies, announced the appointment of Steve Arkinstall, D.Phil., as Chief Executive Officer.

January 8, 2020
·
3 min read
Biotech Beach

n-Lorem Foundation established to charitably provide antisense medicines to treat patients with ultra-rare diseases

Foundation to custom design and provide “n-of 1" experimental ASO medicines to patients with extremely rare diseases for free

January 8, 2020
·
3 min read
Business

Schrödinger and Bayer Collaborate to Co-Develop de novo Design Technology to Accelerate Drug Discovery

Schrödinger and Bayer (BAYN: DE) today announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs.

January 8, 2020
·
3 min read
Business

Verastem Oncology Announces Global Licensing Agreement with Chugai Pharmaceutical Co., Ltd. to Develop and Commercialize RAF/MEK Inhibitor CH5126766

Combination of Defactinib and CH5126766 Shows Promise in Treating KRAS Mutant Solid Tumors in Clinical Trial

January 8, 2020
·
9 min read